Clinical significance of an anti-Dib assessed by flow cytometry
By: R. Leger, P. Arndt, A. CO, L. O’brien and G. Garratty
Paid access
|Nov 2020Authors
R. Leger
Research Associate, American Red Cross Blood Services, Los Angeles, United States
P. Arndt
Senior Research Associate, American Red Cross Blood Services, Southern California Region, Los Angeles, United States
A. CO
Reference Specialist, American Red Cross Blood Services, Southern California Region, Los Angeles, United States
L. O’brien
Associate Pathologist, Santa Monica-UCLA Medical Center, Santa Monica, United States
G. Garratty
Scientific Director, American Red Cross Blood Services, Southern California Region, Los Angeles, United States
DOI: https://doi.org/10.21307/immunohematology-2019-715 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 93 - 96
Published on: Nov 9, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2020 R. Leger, P. Arndt, A. CO, L. O’brien, G. Garratty, published by American National Red Cross
This work is licensed under the Creative Commons License.